Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities

• Main Authors: Wahiba Oualikene-Gonin (Author), Marie-Christine Jaulent (Author), Jean-Pierre Thierry (Author), Sofia Oliveira-Martins (Author), Laetitia Belgodère (Author), Patrick Maison (Author), Joël Ankri (Author), The Scientific Advisory Board of ANSM (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Artificial intelligence tools promise transformative impacts in drug development. Regulatory agencies face challenges in integrating AI while ensuring reliability and safety in clinical trial approvals, drug marketing authorizations, and post-market surveillance. Incorporating these technologies int...